Prostate specific antigen reverse transcriptase-polymerase chain reaction assay in preoperative staging of prostate cancer

Journal of Urology

Volumn 158, Issue 5, 1997, Pages 1870-1875

  Ignatoff, Jeffrey M ^a   Oefelein, Michael G ^a,b   Watkin, William ^a   Chmiel, Joan S ^a   Kaul, Karen L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WRIGHT PATTERSON AIR FORCE BASE   (United States)

Author keywords

Neoplasm staging; Prostate specific antigen; Prostatic neoplasms; Reverse transcriptase

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030849409     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64150-8     Document Type: Article

References (26)

1. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J.A.M.A., 270: 948, 1993.
2. Epstein, J. I., Walsh, P. C., Carmichael, M. and Brendler, C. B.: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. J.A.M.A., 271: 368, 1994.
3. Epstein, J. I., Walsh, P. C. and Brendler, C. B.: Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stage T1a and T1b) and on needle biopsy (stage T1c). J. Urol., 152: 1721, 1994.
4. Smith, D. S. and Catalona, W. J.: The nature of prostate cancer detected through prostate specific antigen based screening. J. Urol., 152: 1732, 1994.
5. Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I. and Walsh, P. C.: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol., 150: 110, 1993.
6. Epstein, J. I., Pizov, G. and Walsh, P. C.: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer, 71: 3582, 1993.
7. Katz, A. E., Olsson, C. A., Raffo, A. J., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C. and Buttyan, R.: Molecular staging of prostate cancer with the use of an enhanced reverse-transcriptase-PCR assay. Urology, 43: 765, 1994.
8. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Powell, C. T., Fair, W. R., Samadi, D. S., Huryk, R. F., DeBlasio, A., Edwards, E. T., Wise, G. J. and Heston, W. D. W.: Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54: 6306, 1994.
9. Katz, A. E., de Vries, G. M., Begg, M. D., Raffo, A. J., Cama, C., O'Toole, K., Buttyan, R., Benson, M. C. and Olsson, C. A.: Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer, 75: 1642, 1995.
10. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vihko, P., Mulholland, S. G. and Gomella, L. G.: Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52: 6110, 1992.
11. Seiden, M. V., Kantoff, P. W., Krithivas, K., Propert, K., Bryant, M., Haltom, E., Gaynes, L., Kaplan, I., Bubley, G., DeWolf, W. and Sklar, J.: Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol., 12: 2634, 1994.
12. Ghossein, R. A., Scher, H. I., Gerald, W. L., Kelly, W. K., Curley, T., Amsterdam, A., Zhang, Z. F. and Rosai, J.: Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J. Clin. Oncol., 13: 1195, 1995.
13. Olsson, C. A., De Vries, G. M., Raffo, A. J., Benson, M. C., O'Toole, K., Cao, Y., Buttyan, R. E. and Katz, A. E.: Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. J. Urol., 155: 1557, 1996.
14. Sokoloff, M. H., Cho-lea, T., Kaboo, R., Nelson, S., Ko, J., Dorey, F., Figlin, R. A., Pang, S., deKernion, J. B. and Belldegrun, A.: Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J. Urol., 156: 1560, 1996.
15. Smith, M. R., Biggar, S., and Hussain, M.: Prostate-specific antigen messenger RNA is expressed in nonprostate cells: implications for detection of micrometastases. Cancer Res., 55: 2640, 1995.
16. Schroeder, F. H., Hermanek, P., Denis, L., Fair, W. R., Gospodarowicz, M. K. and Pavone-Macaluso, M.: The TNM classification of prostate cancer. Prostate, suppl., 4: 129, 1992.
17. Epstein, J. I.: The evaluation of radical prostatectomy specimens: therapeutic and prognostic implications. Path. Ann., 26: 159 1991.
18. Oefelein, M. G., Kaul, K., Herz, B., Blum, M. D., Holland, J. M., Keeler, T. C., Cook, W. A. and Ignatoff, J. M.: Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J. Urol., 155: 238, 1996.
19. Schulz, P., Stucka, R., Feldmann, H., Combriato, G., Klobeck, H. G., and Fittler, F.: Sequence of a cDNA clone encompassing the complete mature human prostate specific antigen (PSA) and an unsliced leader sequence. Nucleic Acids Res., 16: 6226, 1988.
20. Wood, D. P., Jr., Banks, E. R., Humphreys, S., McRoberts, J. W. and Rangnekar, V. M.: Identification of bone marrow micrometastases in patients with prostate cancer. Cancer, 74: 2533, 1994.
21. Wood, D. P., Weinstein, M., Humphries, S., Rangnekar, V. M.: Prognostic significance of circulating prostate cells. J. Urol., part 2, 155: 418A, abstract 429, 1996.
22. Edelstein, R. A., Zietman, A. L., de las Morenas, A., Krane, R. J., Babayan, R. K., Dallow, K. C., Traish, A. and Moreland, R. B.: Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Urology, 47: 370, 1996.
23. Monne, M., Croce, C. M., Yu, H., Diamandis, E. P.: Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res., 54: 6344, 1994.
24. Yu, H., Diamandis, E. P., Levesque, M., Asa, S. L., Monne, M. and Croce, C. M.: Expression of prostate-specific antigen gene by a primary ovarian carcinoma. Cancer Res., 55: 1603, 1995.
25. Oefelein, M. G., Ignatoff, J. M., Herz, B. and Kaul, K. Hematogenous dissemination of prostate cells during radical prostatectomy. Lancet, 347: 3011, 1995.
26. Eschwege, P., Dumas, F., Blanchet, P., LeMaire, V., Benoit, G., Jardin, A., Lacour, B. and Loric, S.: Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet, 346: 1528, 1995.